findmyKOL
Clinical trialNCT00407563CompletedPhase 2Interventional

Bevacizumab With Abraxane in Patients With Recurrent Ovarian/ Peritoneal Cancer

SponsorAccelerated Community Oncology Research NetworkEnrollment48Epithelial Ovarian CancerPrimary Peritoneal Carcinoma
View the registry record on ClinicalTrials.gov

Summary

The registered summary isn't in our current data snapshot. Read it on the ClinicalTrials.gov record ↗. Why? →

Investigators

The overall officials registered on this study. Names that resolve to a findmyKOL profile link to it; the rest are shown as registered.

A profile link is shown only when the registered name resolves to a person record with a confident, namesake-checked match; ambiguous names stay unlinked.

Sites

11 registered facilities, with the per-site recruitment status where the registry publishes one. ClinicalTrials.gov does not publish per-site enrollment counts.

United States
  • Little Rock Hematology Oncology

    Little Rock, Arkansas, United States

  • Wilshire Oncology Medical Group, Inc.

    La Verne, California, United States

  • Northeast Georgia Cancer Care, Llc

    Athens, Georgia, United States

  • Southeastern Gynecologic Oncology, Llc

    Atlanta, Georgia, United States

  • North Idaho Cancer Center

    Coeur d'Alene, Idaho, United States

  • Hematology-Oncology Centers of the Northern Rockies

    Billings, Montana, United States

  • Mid-Ohio Oncology/hematology

    Columbus, Ohio, United States

  • Pennsylvania Oncology Hematology Assoc.

    Philadelphia, Pennsylvania, United States

  • Chattanooga'S Program in Women'S Oncology

    Chattanooga, Tennessee, United States

  • the West Clinic

    Memphis, Tennessee, United States

  • Cancer Specialists of Tidewater, Ltd

    Chesapeake, Virginia, United States

Site investigator names are published by ClinicalTrials.gov only while a study recruits, so completed studies list sites without them.

Drugs studied

No drug or biological interventions are in our data for this study — it may test a procedure, device or behavioral intervention, or the intervention list isn't in our current snapshot. See the registry record ↗. Why? →

Registration & key dates

Registry attributes as recorded on the ClinicalTrials.gov study record.

Start
31 Jan 2007
Primary completion
28 Feb 2011
Completion
28 Feb 2011
Last update posted
5 Apr 2012
Registered enrollment
48
Registry id
NCT00407563

Source: ClinicalTrials.gov, via the CTTI AACT database, data as of 12 Jul 2026. Registry facts are shown as registered by the study sponsor; findmyKOL does not interpret them.